Biotech

Metallic arrow symbols illuminated by blue and magenta lights forming a graph on blue and magenta background
Biotech

Excellergy emerges with $70M and ex-Dermavant CEO at the helm

The California biotech is developing a new drug class in hopes of redefining the standard of care for several allergic diseases.
Gabrielle Masson Oct 13, 2025 10:50am
long shot miss basketball hoop fail shoot

Tvardi's STAT3 inhibitor flunks IPF trial amid high dropout rate

Oct 13, 2025 9:25am
10102025

Neuroinflammation a Key Underlying Factor in Alzheimer’s Disease Risk

Oct 13, 2025 8:00am
Fierce Fundraising Tracker image 2025

Fierce Biotech Fundraising Tracker: Excellergy, Expedition & more

Oct 13, 2025 8:30am
Learn strategies to address PFAS challenges facing the medical device industry

Understanding the Impact of PFAS "Forever Chemicals" on Medical Devices

Oct 13, 2025 8:00am
Gut stomach

Gilead, Arcus keep TIGIT dream alive with 27-month OS data

Oct 13, 2025 7:05am